Being recognized as a Renowned organization, INOVINE Scientific meetings takes pride to introduce the commencement of 5th World Congress on Diabetes & Endocrinology (Diabetes congress 2023) from July 12-13, 2023 at Paris, France. INOVINE Scientific meeting welcomes all the scientists, physicians, surgeons, young researchers, industrial delegates and talented student communities in the field of diabetic medicine to attend this Diabetes Conferences, where all the aspects of diabetes will be discussed under single roof. Diabetes congress 2023 will be an excellent amalgamation of academia and industry as it involves every aspects of empirical and conceptual thinking in exploring new dimensions in this field.  It is open to all types of research methodologies both from academia and industry.

Diabetes congress 2023 is an international platform for presenting research about diabetes management and therapeutics, exchanging ideas about it and thus, contributes to the dissemination of knowledge in management of the disease for the benefit of the society where the future of management and novel therapeutics for the disease intersects.

There are about 60 million people with diabetes in the European Region, or about 10.3% of men and 9.6% of women aged 25 years and over. Prevalence of diabetes is increasing among all ages in the European Region, mostly due to increases in overweight and obesity, unhealthy diet and physical inactivity. Prevalence of diabetes in the French population is estimated at 6%, including patients treated with oral antidiabetic medications and/or insulin (4.4%), [5] patients treated with diet alone (0.6%) [6] and individuals with undiagnosed diabetes (1%) [7]. Type 2 diabetes accounts for the vast majority of cases (92%).

Theme: Novel therapeutic approaches for prevention of diabetes and exploring the diabetic complications.